Mar 28, 2024
Press communication Lund, Sweden, March 28, 2024 This is a translation of the Swedish press release published 2024-03-28 Neola Medical’s product for lung monitoring of preterm born infants, Neola®, was selected by Stanford as one of the top ten most promising...
Mar 22, 2024
“With great potential for the youngest” – reads the title as CEO Hanna Sjöström joins venture capitalist Jan Dahlqvist in this week’s Lejonkulan, the new podcast of Rapidus, which for the first time hosts a listed company. Listen to the entire...
Mar 20, 2024
Press communication Lund, Sweden, March 20, 2024 This is a translation of the Swedish press release published 2024-03-20 The initial months of 2024 continue with intensive work and positive progress for Neola Medical in preparation for upcoming studies for market...
Mar 14, 2024
CEO Hanna Sjöström continues her work of establishing international contacts with key opinion leaders and expanding the company’s network as part of the preparatory work for the launch of Neola® in the USA. Recently, CEO Hanna Sjöström visited the neonatal...
Mar 13, 2024
Almost all life science companies want to break into the American market. What are the economic, strategic, and political reasons behind this? Hanna Sjöström, CEO of Neola Medical, discusses both what attracts in the USA and what decisions the government would need to...
Mar 11, 2024
Results from a study conducted by world-leading researchers in optical spectroscopy from the Tyndall National Institute, Cork, Ireland, in collaboration with Neola Medical, have been published in the Journal of Biomedical Optics. The purpose of the study was to...